Linkedin Facebook Twitter
Sign up

Clinical Trials & Medical Discoveries

Stay up-to-date on the most recent medical research and scientific discoveries in all areas of healthcare, including testing, diagnosis, and treatment. New products to be tested, upcoming clinical trials and studies, and recently published results are among the announcements of new medical discoveries and breakthroughs. Funding decisions, company performance, and legal news are also included.
Latest Clinical Trials & Medical Discoveries
ImmVira’s oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA’s approval for Clinical Trial in China
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Antengene Announces First Patient Dosed with Claudin 18.2 Antibody-Drug Conjugate ATG-022 for the Treatment of Patients with Advanced or Metastatic Solid Tumors in Australia
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer’s and Parkinson’s diseases conference
Clinical Trials & Medical Discoveries
/ March 31, 2023, 13:12 UTC
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
Clinical Trials & Medical Discoveries
/ March 30, 2023, 21:12 UTC
Noul Co. Ltd – The RIGHT Foundation Commences Research and Development for Supporting Malaria Control
Clinical Trials & Medical Discoveries
/ March 30, 2023, 08:12 UTC
BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies
Clinical Trials & Medical Discoveries
/ March 29, 2023, 22:12 UTC
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
Clinical Trials & Medical Discoveries
/ March 29, 2023, 08:12 UTC
ProfoundBio Highlights Broad Antitumor Activity in Preclinical Models and Trial-in-Progress for PRO1184 at AACR 2023 Annual Meeting
Clinical Trials & Medical Discoveries
/ March 28, 2023, 21:12 UTC
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer
Clinical Trials & Medical Discoveries
/ March 28, 2023, 15:12 UTC
280Bio Provides Update on the KRAS Inhibitor TEB-17231 at the 2023 AACR Annual Meeting
Clinical Trials & Medical Discoveries
/ March 28, 2023, 13:12 UTC
Kintor Pharma’s KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023
Clinical Trials & Medical Discoveries
/ March 28, 2023, 10:12 UTC

Subscribe today and save your spot

News & Trends

Buying Guide

Topics

Generated by Feedzy

Are you in?

Subscribe to receive exclusive content and notifications to your inbox